Profil
Mary Carmen Diez has worked as a VP-Medical Affairs & New Product Commercialization at TiGenix NV since 2014.
Postes actifs de Mary Carmen Diez
| Sociétés | Poste | Début |
|---|---|---|
| TIGENIX NV | Corporate Officer/Principal | 18/09/2014 |
Expériences
Fonctions occupées
Relations
17
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
